uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Vijoice
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/005468
ATC code
L01EM03
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of patients with severe manifestations of PIK3CA-related overgrowth spectrum
MeSH:
Genetic Diseases, Inborn;Growth Disorders
Group:
Antineoplastic agents
Active substances
alpelisib
Marketing Authorisation Holder
Novartis Europharm Limited
MAH
Timeline
Filter by authority:
EMA
Status changed: Opinion → Application withdrawn
14 Mar 2024
status_changed
regulatory
Vijoice | uMedical